Related Experiment Video
Updated: Jun 26, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
Chronic inflammatory diseases and survival among patients with pancreatic cancer in the U.S. Military health system
Jie Lin1, Joel T Moncur2, Kimberly M Greenfield2
1Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA.
Background:
Systemic inflammation promotes the initiation and progression of pancreatic cancer, but the association between chronic inflammatory diseases and survival is less understood. This study aimed to investigate the relationship between chronic inflammatory diseases and survival among patients with pancreatic cancer in the US Military Health System (MHS), a healthcare system with universal access.
Methods:
The study utilized the Military Cancer Epidemiology database (MilCanEpi), a linked database comprising data from the Department of War's Central Cancer Registry (CCR) and the Military Health System (MHS) Data Repository (MDR). The diagnosis of chronic inflammatory diseases was queried in the MilCanEpi database. All-cause death was the study outcome. Multivariable time-dependent Cox proportional hazard regression was used to estimate hazard ratios (HRs) and 95% confidence interval (95% CI) of death associated with chronic inflammatory diseases.
Results:
Four hundred patients had chronic inflammatory diseases concurrent with or following their pancreatic cancer diagnosis, compared to 477 without such a diagnosis. There was a nearly two-fold increased risk of death associated with chronic inflammatory diseases after adjustment for confounders (adjusted HR = 1.77, 95% CI = 1.51-2.06). The association was observed in most subgroups defined by age, comorbidity, tumor stage, tumor grade, and time at diagnosis of chronic inflammatory diseases relative to pancreatic cancer diagnosis.
Conclusion:
Chronic inflammation, characterized by chronic inflammatory diseases, was independently associated with risk of increased all-cause death among patients with pancreatic cancer in the MHS.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis II: Pathophysiology
Cancer Survival Analysis
Acute Pancreatitis II: Clinical Manifestations and Management

